Press Releases

TissueTech, Inc. Awarded Patent for Compositions of Morselized Umbilical Cord and Amniotic Membrane

MIAMI – May 14, 2018 – TissueTech Inc., the pioneer in the development and clinical application of regenerative amniotic tissue-based products, announced that it has been awarded patent 9,808,491 by the U.S. Patent Trademark Office. The patent applies to the use of a gel composition comprising morselized placental amniotic membrane and/or morselized umbilical cord. as […]

TissueTech Appoints Dr. Frank Young Executive Vice President of Regulatory Affairs

MIAMI, FL – May 10, 2018 – TissueTech Inc., pioneers of the development and clinical application of amniotic tissue-based products, announced today the appointment of Dr. Frank Young as Executive Vice President of Regulatory Affairs. “Dr. Young’s appointment continues TissueTech’s tradition as a leader in innovation and quality,” said Amy Tseng, Chief Executive Officer of […]

Clinical Evidence Presented at SAWC on Application of AMNIOX Medical Products

Four Posters Demonstrate the Clinical Benefits of NEOX ® Wound Allograft Presented at SAWC MIAMI, FL – May 8, 2018 – AMNIOX Medical, Inc., a TissueTech, Inc. company, highlighted four clinical posters demonstrating the effectiveness of NEOX® Wound Allograft at the Symposium on Advanced Wound Care (SAWC) in April. The presentations illustrate applications of NEOX […]

AMNIOX Obtains Federal Supply Schedule Contract for NEOX® and CLARIX® Product Lines

ATLANTA, GA – April 17, 2017 — AMNIOX Medical, Inc., a TissueTech, Inc. company, announced a new Federal Supply Schedule contract for its NEOX and CLARIX product lines. The agreement provides the Military Health System broad access to NEOX Wound Allograft – indicated for use as a wound covering for dermal ulcers and defects – […]

Bio-Tissue® Research Further Demonstrates Effectiveness of Cryopreserved Amniotic Membrane for Ocular Surface Healing

LOS ANGELES, May 2, 2017 – Bio-Tissue, Inc., a business unit of TissueTech™, Inc., announces the presentation of key research at this week’s American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, May 5-9, further demonstrating the clinical effectiveness of PROKERA, its biologic corneal bandage with cryopreserved amniotic membrane tissue. The studies being presented […]

Bio-Tissue Announces Global Online Purchase Availability for Cliradex Light & Website Relaunch

Bio-Tissue, a business unit  of TissueTech, Inc., today announced the global online availability of its newest product Cliradex Light advanced foaming eyelid cleanser on its newly redesigned website, International purchases may be directed to Amazon Marketplace. Cliradex Light – which was launched last year and quickly realized high consumer and physician office demand – is […]

New Clinical Evidence Continues to Support the Effectiveness and Value of AMNIOX Medical Product

Nine Posters Demonstrating the Clinical Benefits of NEOX ® Wound Allograft Presented at SAWC ATLANTA, GA – May 8, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company, announced today that nine clinical posters demonstrating the effectiveness of NEOX® Wound Allograft – Amniox’s proprietary cryopreserved Umbilical Cord and Amniotic Membrane (UC/AM) product for chronic wound management – were […]

Amniox Medical Enters into Agreement with Intalere

ATLANTA, GA – June 8, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company has announced an agreement with Intalere, to serve their members with its market leading human tissue allograft technology composed of both umbilical cord and amniotic membrane for wound healing and soft-tissue repair. Intalere is a professional supply chain company offering a comprehensive […]

Study Demonstrating Improved Outcomes in Pain Reduction and Function for Discectomy Patients with CLARIX® 100 Highlighted in Medical Journal

Proprietary technology demonstrates significant improvement in short-term and long-term outcomes. ATLANTA – July 10, 2017 – AMNIOX Medical, Inc., a TissueTechTM, Inc. company, announced today that the results of a clinical study on the efficacy of CLARIX Cryopreserved Amniotic Membrane in lumbar microdiscectomy surgery was published in the May 2017 online issue of Clinical Spine Surgery. The […]

TissueTech, Inc. Names Dr. Herbert B. Slade as Chief Medical Officer

MIAMI – August 1, 2017 – TissueTech, Inc. announced today that Herbert B. Slade, MD, has been named the company’s Chief Medical Officer (CMO). Dr. Slade, who will lead the execution of TissueTech’s clinical research strategies and be the primary liaison for medical affairs, has more than 25 years of healthcare industry-based experience, most recently […]